1. 2023
  2. Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial

    ICECREAM study group, 15 Mar 2023, In: Trials. 24, 1, p. 193

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Unmasking a hepatitis C genotype 3a/1b dual infection in an individual treated with elbasvir/grazoprevir

    van der Pluijm, R. W., Smits, L. P., Rebers, S. P., Schinkel, J. & van der Valk, M., 1 Mar 2023, In: Journal of hepatology. 78, 3, p. e95-e96

    Research output: Contribution to journalComment/Letter to the editorAcademic

  4. Dengue, chikungunya and Zika virus infections among Dutch travellers to Suriname: a prospective study during the introduction of chikungunya and Zika virus, 2014 to 2017

    Overbosch, F. W., Schinkel, J., Matser, A., Koen, G., Prange, I., Prins, M. & Sonder, G. J., 1 Jan 2023, In: Euro surveillance. 28, 2

    Research output: Contribution to journalArticleAcademicpeer-review

  5. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

    the Swiss HIV Cohort Study, EuroSIDA, ATHENA Observational Cohort Study & ANRS CO3 Aquitaine Cohort, 2023, (E-pub ahead of print) In: Journal of hepatology.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2022
  7. Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

    Sliepen, K., Radić, L., Capella-Pujol, J., Watanabe, Y., Zon, I., Chumbe, A., Lee, W-H., de Gast, M., Koopsen, J., Koekkoek, S., del Moral-Sánchez, I., Brouwer, P. J. M., Ravichandran, R., Ozorowski, G., King, N. P., Ward, A. B., van Gils, M. J., Crispin, M., Schinkel, J. & Sanders, R. W., 1 Dec 2022, In: Nature communications. 13, 1, 7271.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus

    Chumbe, A., Urbanowicz, R. A., Sliepen, K., Koekkoek, S. M., Molenkamp, R., Tarr, A. W., Ball, J. K., Schinkel, J. & van Gils, M. J., 1 Nov 2022, In: Journal of general virology. 103, 11

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Structure of the hepatitis C virus E1E2 glycoprotein complex

    Torrents de la Peña, A., Sliepen, K., Eshun-Wilson, L., Newby, M. L., Allen, J. D., Zon, I., Koekkoek, S., Chumbe, A., Crispin, M., Schinkel, J., Lander, G. C., Sanders, R. W. & Ward, A. B., 21 Oct 2022, In: Science. 378, 6617, p. 263-269 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study

    for EuroSIDA, the Swiss HIV Cohort Study, and the ATHENA Observational Cohort, 1 Oct 2022, In: Open forum infectious diseases. 9, 10, p. ofac508 ofac508.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Uitbraak van monkeypox: een nieuwe pandemie?

    de Stoppelaar, S. F., Hoornenborg, E., van Rijckevorsel, G., Vollaard, A., Brandwagt, D. A. H., de Vries, H. J. C., Schinkel, J., Welkers, M. R. A. & Goorhuis, A., 8 Sep 2022, In: Nederlands tijdschrift voor geneeskunde. 166

    Research output: Contribution to journalArticleProfessional

Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 83205